Advertisement

Topics

ProSolv CardioVascular Company Profile

00:53 EST 22nd February 2019 | BioPortfolio

Founded in 1989 as Problem Solving Concepts, Inc. (ProSolv) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv CardioVascular's software solutions consist of advanced reporting and image management software, comprehensive support services and integration with third-party clinical applications. The Synapse(TM) ProSolv(R) cardiovascular Enterprise Image and Information Management solution improves physician productivity, enhances customer revenue opportunities, automates complex medical imaging workflow, and maximizes customers' return on investment in capital equipment and clinical information systems. The company is headquartered in Indianapolis, Indiana. For more information visit the ProSolv CardioVascular website at www.prosolv.com.


News Articles [594 Associated News Articles listed on BioPortfolio]

Use of bivalirudin for anticoagulation in interventional cardiovascular procedures

(Cardiovascular Innovations and Applications) In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 2, 2018, pp. 149-162(14); DOI: 10.15212/CVIA.2017.0045 Zhen Ge, Jaya ...

[Articles] SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

SGLT2i have moderate benefits on atherosclerotic major adverse cardiovascular events that seem confined to patients with established atherosclerotic cardiovascular disease. However, they have robust b...

Researchers reveal link between autoimmune and cardiovascular disease in mice

People with autoimmune diseases such as psoriasis, lupus and rheumatoid arthritis are at high risk of developing cardiovascular disease, even though none of these conditions seem to target the cardiov...

[Articles] Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor ag...

Albiglutide Beats Placebo for Cardiovascular Events in T2DM

THURSDAY, Oct. 4, 2018 -- For patients with type 2 diabetes and existing cardiovascular disease, albiglutide results in fewer cardiovascular events, according to a study published online Oct. 2 in The...

Weight Loss Drug Not Found to Increase Cardiovascular Events

NewsResearchers discovered a breakthrough weight loss drug that proves to be the first that demonstrates cardiovascular safety in a dedicated cardiovascular outcomes trial.

Weight Loss Drug Does Not Found to Increase Cardiovascular Events

NewsResearchers discovered a breakthrough weight loss drug that proves to be the first that demonstrates cardiovascular safety in a dedicated cardiovascular outcomes trial.

Aspirin use associated with reduction in cardiovascular events but increase in bleeding risk

1. In this systematic review and meta-analysis, while aspirin use among patients without cardiovascular disease was associated with fewer adverse cardiovascular events, it was not associated with a r...

PubMed Articles [1742 Associated PubMed Articles listed on BioPortfolio]

Surface engineered excipients: III. Facilitating direct compaction tableting of binary blends containing fine cohesive poorly-compactable APIs.

Direct compaction tableting, a desired manufacturing option, is infeasible for blends containing fine cohesive poorly-compactable APIs at higher drug loadings. In this study, the feasibility of using ...

Association of Change in Cardiovascular Risk Factors With Incident Cardiovascular Events.

There is consistent evidence of the association between ideal cardiovascular health and lower incident cardiovascular disease (CVD); however, most studies used a single measure of cardiovascular healt...

Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have positive effects on weight loss, blood pressure, hyperlipidemia, and glycemic control. They exhibit a broad range of effects on the cardiovas...

3D bioprinting for cardiovascular regeneration and pharmacology.

Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. Compared to traditional therapeutic strategies, three-dimensional (3D) bioprinting is one of the most advanced techn...

Gout and cardiovascular disease: crystallized confusion.

Gout is associated with the risk of cardiovascular morbidity and mortality, but the biological relationship between the two remains uncertain. The demonstration of reduction of cardiovascular risk wit...

Clinical Trials [3044 Associated Clinical Trials listed on BioPortfolio]

Cardiovascular Disease Cohort in Guangdong Province

Patients with cardiovascular diseases from Guangdong province will be recruited and followed up for at least 4 years to evaluate the risk factors for cardiovascular-related mortality and d...

Factors Influencing Cardiovascular Prognosis

The purpose of this study is to identify risks for cardiovascular events in a follow up period of 10 years.

Work Organization and Cardiovascular Disease

To determine the combined effects of job strain and social isolation on cardiovascular morbidity and mortality.

Role of Vitamin D in Secondary Prevention of Cardiovascular Events

The purpose of this study is to determine if Vitamin D supplementation helps prevent recurrent cardiovascular events, such as heart attack or stroke, in patients who have already experienc...

Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians

The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.

Companies [620 Associated Companies listed on BioPortfolio]

ProSolv CardioVascular

Founded in 1989 as Problem Solving Concepts, Inc. (ProSolv) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solut...

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate ...

Cardiovascular Consultants Ltd.

Cardiovascular Consultants Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate c...

Embrella Cardiovascular, Inc.

Embrella Cardiovascular™, Inc., is dedicated to creating a new standard-of-care for cerebral embolic protection during cardiovascular procedures. Embrella's Embolic Deflector...

Cardiovascular Consultants

Cardiovascular Consultants is a medical practice that specializes exclusively in the diagnosis, treatment, prevention and management of cardiovascular diseases and conditions. What makes us different ...

More Information about "ProSolv CardioVascular" on BioPortfolio

We have published hundreds of ProSolv CardioVascular news stories on BioPortfolio along with dozens of ProSolv CardioVascular Clinical Trials and PubMed Articles about ProSolv CardioVascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ProSolv CardioVascular Companies in our database. You can also find out about relevant ProSolv CardioVascular Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record